Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial
Authors
Kenichi A. Tanaka (ORCID: https://orcid.org/0000-0002-5051-1365)
Sigurd Knaub
Jerrold H. Levy (ORCID: https://orcid.org/0000-0003-3766-4962)
Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial
Kenichi A. Tanaka, Sigurd Knaub, Jerrold H. Levy, Justyna Bartoszko et al.
Citations
7 citations
Journal
BMJ Open
Topics
Blood transfusion and management
Field-Weighted Citation Impact (FWCI)
1.56
article
Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial
Kenichi A. Tanaka, Sigurd Knaub, Jerrold H. Levy, Justyna Bartoszko, Keyvan Karkouti, Jeannie Callum, Cristina Solomon
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(8)
Institutions
University Health Network (CA), Duke University (US), University of Toronto (CA), Queen's University (CA), Women's College Hospital (CA), Octapharma (Switzerland) (CH), University of Oklahoma Health Sciences Center (US)
Funders
University of Toronto, Octapharma, Canadian Institutes of Health Research